Best Agrolife (539660) Q4 24/25 earnings summary

Executive summary

• Achieved significant operational turnaround in Q4 FY25, reducing quarterly loss from INR 92 crore to INR 20-24 crore year-over-year, driven by cost optimization and operational efficiency.

• Revenue for Q4 FY25 rose 103% year-over-year to INR 274 crore, supported by improved seasonal conditions.

• Focused on branded, patented products and innovation, with three new launches planned and a strong R&D pipeline, including biopesticides for FY26.

• International expansion underway, with exports initiated and patent registrations progressing in multiple countries.

• Final dividend of INR 3 per share recommended for FY 2024-25, subject to shareholder approval.

Financial highlights

• Q4 FY25 revenue: INR 274 crore (up from INR 135 crore in Q4 FY24).

• Q4 EBITDA improved from negative INR 67 crore to positive INR 4 crore year-over-year; EBITDA margin at 2%.

• FY25 consolidated revenue: INR 1,818.89 crore (down from INR 1,876.48 crore in FY24); standalone revenue: INR 1,804.66 crore (up from INR 1,149.68 crore).

• Gross margin improved from 24.7% to 29.5% year-over-year.

• Operating cash flow increased to INR 228 crore in FY25 from INR 35 crore in FY24; inventory reduced by INR 185 crore.

Outlook and guidance

• No specific revenue or volume guidance for FY26; focus is on profitability, margin improvement, and cash flow.

• EBITDA margin targeted in the 15-18% range for FY26.

• Expecting INR 150 crore additional revenue from three new patented products in FY26.

• Commitment to launch 3-4 patented crop protection solutions annually and expand R&D capabilities.

• Biopesticides launch planned for FY26, reinforcing innovation pipeline.